Invesaro

Stocks Comparison

Envista vs DENTSPLY SIRONA: revenue, profit, margins and growth compared

Envista brought in $2.7B of revenue in fiscal 2025, DENTSPLY SIRONA $3.7B in fiscal 2025. Revenue changed by +8.3% at Envista and -3.0% at DENTSPLY SIRONA on the year before, so Envista grew faster. Envista kept 1.7% of its revenue as net profit, DENTSPLY SIRONA -16.3%. Free cash flow was $230.4M at Envista and $104M at DENTSPLY SIRONA.

Open the NVST pageOpen the XRAY page

Side by side, latest fiscal year

NVSTXRAY
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$2.7B$3.7B
Revenue growth+8.3%-3.0%
Net income$47M-$598M
Net margin1.7%-16.3%
Free cash flow$230.4M$104M
Free cash flow margin8.5%2.8%
Earnings per share (diluted)$0.28-$3.00
Cash$1.2B$326M
Debt$1.4B$2.3B
Price to earnings85.5n/a
Market value$3.8B$1.9B
Dividend yieldn/a6.81%
Rank by revenue in sector#92 of 523 · Health care#76 of 523 · Health care

Over the years

Revenue
NVST FY2019: $2.8BNVST FY2019: $2.3BNVST FY2020: $1.9BNVST FY2021: $2.5BNVST FY2022: $2.6BNVST FY2023: $2.6BNVST FY2024: $2.5BNVST FY2025: $2.7BXRAY FY2018: $4BXRAY FY2019: $4BXRAY FY2020: $3.3BXRAY FY2021: $4.2BXRAY FY2022: $3.9BXRAY FY2023: $4BXRAY FY2024: $3.8BXRAY FY2025: $3.7BFY18FY19FY20FY21FY22FY23FY24FY25
NVST $2.7BXRAY $3.7B
Net income
NVST FY2019: $230.7MNVST FY2019: $217.6MNVST FY2020: $33.3MNVST FY2021: $340.5MNVST FY2022: $243.1MNVST FY2023: -$100.2MNVST FY2024: -$1.1BNVST FY2025: $47MXRAY FY2018: -$1BXRAY FY2019: $256MXRAY FY2020: -$73MXRAY FY2021: $411MXRAY FY2022: -$950MXRAY FY2023: -$132MXRAY FY2024: -$910MXRAY FY2025: -$598MFY18FY19FY20FY21FY22FY23FY24FY25
NVST $47MXRAY -$598M
Net margin
NVST FY2019: 8.1%NVST FY2019: 9.5%NVST FY2020: 1.7%NVST FY2021: 13.6%NVST FY2022: 9.5%NVST FY2023: -3.9%NVST FY2024: -44.6%NVST FY2025: 1.7%XRAY FY2018: -25.4%XRAY FY2019: 6.4%XRAY FY2020: -2.2%XRAY FY2021: 9.7%XRAY FY2022: -24.2%XRAY FY2023: -3.3%XRAY FY2024: -24.0%XRAY FY2025: -16.3%FY18FY19FY20FY21FY22FY23FY24FY25
NVST 1.7%XRAY -16.3%
Revenue growth
NVST FY2019: -19.7%NVST FY2020: -15.6%NVST FY2021: +30.1%NVST FY2022: +2.4%NVST FY2023: -0.1%NVST FY2024: -2.2%NVST FY2025: +8.3%XRAY FY2019: +0.9%XRAY FY2020: -17.0%XRAY FY2021: +26.7%XRAY FY2022: -7.3%XRAY FY2023: +1.1%XRAY FY2024: -4.3%XRAY FY2025: -3.0%FY19FY20FY21FY22FY23FY24FY25
NVST +8.3%XRAY -3.0%
Free cash flow
NVST FY2019: $327.9MNVST FY2019: $319.7MNVST FY2020: $236.2MNVST FY2021: $306.9MNVST FY2022: $107MNVST FY2023: $217.5MNVST FY2024: $302.7MNVST FY2025: $230.4MXRAY FY2018: $317MXRAY FY2019: $516MXRAY FY2020: $562MXRAY FY2021: $515MXRAY FY2022: $368MXRAY FY2023: $228MXRAY FY2024: $281MXRAY FY2025: $104MFY18FY19FY20FY21FY22FY23FY24FY25
NVST $230.4MXRAY $104M

Fiscal years as each company reports them; the two may end in different months.

Questions about Envista and DENTSPLY SIRONA

Which is bigger by revenue, Envista or DENTSPLY SIRONA?

DENTSPLY SIRONA is bigger by revenue: $3.7B in fiscal 2025, against $2.7B for Envista in fiscal 2025.

Which keeps more of its revenue as profit, Envista or DENTSPLY SIRONA?

Envista had a net margin of 1.7% in fiscal 2025; DENTSPLY SIRONA had -16.3% in fiscal 2025.

Which grew revenue faster, Envista or DENTSPLY SIRONA?

In their latest fiscal years revenue changed by +8.3% at Envista and -3.0% at DENTSPLY SIRONA.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

Compare more companies